Chapter 9: Problem 6
What three criteria must a human disorder fulfill to be classified as a hereditary mitochondrial disease?
Chapter 9: Problem 6
What three criteria must a human disorder fulfill to be classified as a hereditary mitochondrial disease?
All the tools & learning materials you need for study success - in one app.
Get started for freeWhy is the rate of mutation in mitochondrial DNA higher than that in nuclear DNA but the incidence of genetic diseases caused by mutations in mitochondrial DNA relatively low?
In Drosophila subobscura, the presence of a recessive gene called grandchildless (gs) causes the offspring of homozygous females, but not those of homozygous males, to be sterile. Can you offer an explanation as to why females and not males are affected by the mutant gene?
Mutations in mitochondrial DNA appear to be responsible for a number of neurological disorders, including myoclonic epilepsy and ragged-red fiber disease, Leber's hereditary optic neuropathy, and Kearns-Sayre syndrome. In each case, the disease phenotype is expressed when the ratio of mutant to wild-type mitochondria exceeds a threshold peculiar to each disease, but usually in the 60 to 95 percent range. (a) Given that these are debilitating conditions, why has no cure been developed? Can you suggest a general approach that might be used to treat, or perhaps even cure, these disorders? (b) Compared with the vast number of mitochondria in an embryo, the number of mitochondria in an ovum is relatively small. Might such an ooplasmic mitochondrial bottleneck present an opportunity for therapy or cure? Explain.
The maternal-effect mutation bicoid ( \(b c d\) ) is recessive. In the absence of the bicoid protein product, embryogenesis is not completed. Consider a cross between a female heterozygous for the bicoid alleles \(\left(b c d^{+} / b c d^{-}\right)\) and a male homozygous for the mutation \(\left(b c d^{-} / b c d^{-}\right)\) (a) How is it possible for a male homozygous for the mutation to exist?. (b) Predict the outcome (normal vs. failed embryogenesis) in the \(\mathrm{F}_{1}\) and \(\mathrm{F}_{2}\) generations of the cross described.
Tools are now available to sequence mtDNAs from an individual's genome sequence data to accurately measure heteroplasmy and to easily recognize the most functionally important mitochondrial variants. What is the significance of these tools for the diagnosis of human mtDNA diseases? If your sibling is diagnosed with a mitochondrial degenerative neurological disorder, would you want your mtDNA to be sequenced for mutations and heteroplasmy?
What do you think about this solution?
We value your feedback to improve our textbook solutions.